Cold virus 'treats prostate cancer' for Birmingham patient

A patient in Birmingham has undergone landmark gene therapy to treat prostate cancer.

The treatment, developed by doctors at University Hospital in Birmingham over the past 15 years, uses a virus modified from the common cold to deliver a powerful chemotherapy drug which at the same time stimulates the patient's immune system helping them fight the disease.

Bernard Ward is the first of 20 people to take part in the trial which is testing how safe the therapy is, the hospital said.